If you’ve started looking into GLP-1 medications (semaglutide or tirzepatide) for weight or metabolic reasons, you’ve probably already encountered the language gap. Brand names: the FDA-approved branded versions. Generic active ingredients: semaglutide, tirzepatide. And then a third category: “compounded semaglutide” or “compounded tirzepatide,” available through cash-pay clinics, often at a fraction of the brand-name price.
If you’re trying to figure out which version is right for you, the honest answer requires a clearer picture than either side of the marketing usually gives. Here’s the version we walk patients through at Align.
What “compounded” actually means
A compounded medication is a custom-prepared formulation of an active ingredient (in this case, semaglutide or tirzepatide) made by a licensed compounding pharmacy. Compounding is a long-established practice in U.S. pharmacy law. It’s how patients get medications in custom doses, alternative delivery forms, or formulations the brand-name manufacturer doesn’t offer.
Compounded medications are not FDA-approved in the way brand-name medications are. The active ingredient itself (semaglutide, tirzepatide) is the same chemical compound, but the FDA hasn’t formally reviewed and approved the specific compounded preparation the way it has approved the FDA-approved branded versions.
That distinction matters in three ways:
- The clinical evidence for the active ingredient comes from studies done on the brand-name product. Compounded versions inherit that evidence by virtue of containing the same molecule, but they haven’t been independently tested in the same way.
- The quality and consistency depends entirely on the compounding pharmacy. A reputable 503A or 503B pharmacy operates under federal and state regulation, and quality is high. A sketchy online “research peptide” vendor operates outside the regulated pharmacy system, and quality is unverified. Use is also not legal for human therapeutic purposes.
- The legal status of compounding for any given active ingredient can change. The FDA has historically permitted compounded semaglutide when the brand-name version was on the official drug shortage list. As shortage status changes, so do the legal parameters around compounding.
When we prescribe compounded semaglutide or tirzepatide at Align, we use licensed U.S. compounding pharmacies that are properly registered as 503A or 503B facilities, prepare medications under sterile conditions, and ship in temperature-controlled packaging. The active ingredient is the same as what’s in the brand-name product. The difference is in the regulatory status of the specific preparation.
Why patients consider compounded over brand-name
Three reasons, in order of how often they come up in our consultations:
Cost. Brand-name GLP-1 medications without insurance coverage typically run $1,000 to $1,500 per month at retail pharmacies. Compounded versions through a clinical practice typically run $200 to $400 per month including provider visits. For most cash-pay patients, that’s the deciding factor.
Insurance won’t cover the brand-name. Insurance coverage for brand-name GLP-1 medications has been tightening. Some branded GLP-1 medications are sometimes covered for diagnosed obesity meeting specific BMI and comorbidity criteria. Others are typically covered only for type 2 diabetes. Many patients who would benefit from GLP-1 therapy don’t qualify for coverage and don’t want to pay $1,500 a month out of pocket.
Dose customization. Brand-name medications come in fixed doses (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg for semaglutide). Some patients respond best at intermediate doses or need to ramp slower than the manufacturer’s titration schedule allows. Compounded preparations can be dosed in smaller increments to match individual response.
When brand-name is the better choice
Compounded isn’t always the right answer. The brand-name version is usually preferable when:
- You have insurance coverage that meaningfully reduces the out-of-pocket cost. Even at $50 to $100 a month copay, brand-name can be cheaper than compounded cash-pay.
- You qualify for the manufacturer’s patient assistance program. Novo Nordisk and Eli Lilly both offer income-based assistance that can dramatically reduce the brand-name cost for eligible patients.
- You want the regulatory status and clinical evidence base of the FDA-approved product specifically. Some patients place high value on this even if there’s a cost difference.
- You’ve had complications or atypical responses to compounded versions in the past and your provider wants to switch to a more standardized formulation.
We routinely tell patients during their consultation if we think brand-name is the better fit for their situation. If we can refer you to your insurance for the brand-name version and that’s the right answer, we will.
What about safety?
Both brand-name and compounded GLP-1 medications carry the same biological risks because the active ingredient is the same. The risks specific to the medication class include:
- Common, mild side effects: nausea, mild constipation, reduced appetite, occasional vomiting, mild fatigue
- Less common: more pronounced GI symptoms, acid reflux, diarrhea, headaches
- Serious but rare: pancreatitis, gallbladder issues, severe hypoglycemia (especially when combined with insulin or sulfonylureas), allergic reactions
The risks specific to compounded vs. brand-name are about the source and preparation, not the molecule. A medication compounded by a properly regulated 503A/B pharmacy under sterile conditions, prescribed by a licensed clinician, and shipped in proper packaging carries similar safety risk to the brand-name version. A medication ordered from an unregulated online vendor, prescribed without clinical evaluation, or stored improperly carries dramatically higher risk.
The difference between “compounded GLP-1 from a real clinic with a real provider and a real pharmacy” and “GLP-1 ordered from an online vendor with a 5-minute intake form” is enormous. Don’t conflate them.
Who should NOT take any GLP-1 medication
Independent of brand-name vs. compounded, GLP-1 therapy is contraindicated for:
- Personal or family history of medullary thyroid carcinoma
- Multiple endocrine neoplasia syndrome type 2
- Pregnancy or active plans to become pregnant
- Active eating disorder
- History of pancreatitis
- Known hypersensitivity to GLP-1 receptor agonists
- Patients under 18
Other clinical situations require careful evaluation before prescribing. Your provider should review the full picture before starting you on therapy.
What we do at Align
We prescribe both compounded and brand-name GLP-1 therapy depending on the patient’s situation:
- For patients who qualify for insurance coverage of the brand-name version, we’ll often recommend pursuing that route and refer accordingly
- For cash-pay patients, we typically prescribe compounded semaglutide or tirzepatide through a licensed U.S. compounding pharmacy
- Either way, the protocol includes baseline labs, monthly provider visits during titration, and ongoing monitoring. Not a one-shot prescription.
The Targeted Therapy Intake is $250 (45 to 60 minutes) and the goal is to figure out whether GLP-1 is appropriate for you and which version makes sense. Sometimes the answer is “neither, and here’s what we’d suggest instead.”
What to ask before starting any GLP-1 protocol
If you’re talking to any clinic about GLP-1 therapy, here are the questions worth asking:
- Where does the medication come from? (“A licensed U.S. 503A/B compounding pharmacy” or “From a major retail pharmacy” are the right answers. “A peptide research vendor” or “We prefer not to say” are red flags.)
- What’s included in the monthly fee? Visit + medication + lab review? Or just the prescription?
- Will I have lab work done? GLP-1 therapy benefits from baseline metabolic markers and ongoing monitoring. A clinic that doesn’t order labs is offering a transactional service, not clinical care.
- What’s the provider’s training and licensure? A licensed provider, physician, or PA. Not a “wellness consultant.”
- What’s the cancellation policy? Some online clinics lock patients into 6+ month commitments. Avoid those.
- What happens if I have side effects? A real clinic has a documented protocol for managing nausea, dose adjustment, and pause/discontinuation. A pill-mill operation has none of this.
The bottom line
Compounded semaglutide and tirzepatide are real, legal medications when prescribed and dispensed through proper channels. They’re often the right choice for cash-pay patients. They’re also subject to ongoing regulatory evolution and depend entirely on the quality of the compounding pharmacy and the clinical oversight of the prescribing provider.
If you’re considering GLP-1 therapy, the questions to focus on aren’t “compounded vs. brand-name” in the abstract. They’re:
- What’s my actual situation (insurance status, comorbidities, goals, contraindications)?
- Who’s prescribing it and what’s their training?
- Where does the medication actually come from?
- What clinical monitoring is included?
The answers to those questions matter much more than the brand on the label.
If you want to talk through whether GLP-1 is right for you, our initial visit is free and we’ll be honest about what we recommend for your specific situation. Even if the answer is that you should pursue brand-name through insurance, or that GLP-1 isn’t the right fit at all.